Balakrishnan Vinod Kumar
Overview
Explore the profile of Balakrishnan Vinod Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar R M, T S, Vinod Kumar B, S S, Natarajan V
Cureus
. 2024 Sep;
16(8):e67557.
PMID: 39314565
Background and objective Coronary artery bypass grafting (CABG) surgery patients undergo cardiac rehabilitation (CR) programs postoperatively to improve their course of recovery. The effectiveness of traditional CR programs is hampered...
2.
Senguttuvan N, Singh H, Vinod Kumar B, Kongara R, Suliankatchi Abdulkader R, Anandaram A, et al.
Cardiovasc Revasc Med
. 2023 Feb;
54:25-30.
PMID: 36842933
Background: Patients with symptomatic calcified coronary lesions have poor outcomes. Such lesions require additional atherectomy devices for bed preparation. Aim: To assess the safety and efficacy of OPN balloon in...
3.
Senguttuvan N, Kongara R, Sadhanandham S, Srinivasan N, Periyasamy S, Vinod Kumar B, et al.
Cardiol Res
. 2022 Apr;
13(2):104-109.
PMID: 35465083
Background: Diffuse long coronary lesions are difficult to treat percutaneously. The aim of the present study was to assess the procedural safety and long-term efficacy of the ultra-long (48-mm) drug-eluting...
4.
Muralidharan T, Ramesh S, Vinod Kumar B, Ruia A, Kumar M, Gopalakrishnan A, et al.
Pulm Circ
. 2021 Jun;
11(1):2045894021992678.
PMID: 34104416
Acute pulmonary thromboembolism is associated with high mortality, similar to that of myocardial infarction and stroke. We studied the clinical presentation and management of pulmonary thromboembolism in the Indian population....
5.
Senguttuvan N, Suman F, Paneerselvam T, Malepati B, Ramesh S, Vallivedu M, et al.
Int J Cardiol
. 2021 Feb;
330:1-6.
PMID: 33600846
Introduction: Dual antiplatelet therapy (DAPT) remains the cornerstone of acute coronary syndrome (ACS) management, and ticagrelor is one of the commonly used second antiplatelet agents. There is some evidence to...